Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

The Prostate

Showing results (1411-1420 of 5,911) with videos related to

Pageof 592
Sort By:
The Prostate|March 30, 2026
Impact of Intraprostatic Simultaneous Integrated Boost on Long-Term Outcomes in Unfavorable Intermediate-Risk Prostate Cancer Treated With Dose-Escalated Radiotherapy and Short-Term Androgen Deprivation TherapyCem Onal, Aysenur Elmali, Birhan Demirhan, et al.
The Prostate|March 31, 2026
A Two-Factor Bedside Prognostic Score Integrating Eastern Cooperative Oncology Group (ECOG) Performance Status and Aggressive Metastatic Burden in Metastatic Hormone-Sensitive Prostate CancerKoichiro Kurokawa, Satoshi Yamamoto, Yasutaka Yamada, et al.
The Prostate|March 18, 2026
Exploring the Gut-Prostate Axis: Microbial Signatures Linked to Prostate Volume and Bladder FunctionJonathan Surber, Marie Lork, Yasser Morsy, et al.
The Prostate|March 30, 2026
Development of Machine Learning Models for Predicting Prostate Cancer in Biopsy Candidates Using Prostate-Specific Antigen, Magnetic Resonance Imaging, and Hematologic ParametersDeniz Noyan Özlü, Yusuf Arıkan, Büşra Emir, et al.
The Prostate|May 3, 2026
Non-Cancer Causes of Death in Patients With Metastatic Hormone-Sensitive Prostate Cancer: A Real-World AnalysisMarta Garcia de Herreros, Clara Rodrigo, Laura Ferrer-Mileo, et al.
The Prostate|May 3, 2026
Perioperative Safety and Early Oncologic Outcomes of Salvage Irreversible Electroporation for Radiorecurrent Prostate CancerJarrett Noakes, Katherine Wainwright, Elias Hyams
The Prostate|May 3, 2026
Temporal Patterns and Resolution of Toxicities Following Hypofractionated Salvage Radiotherapy for Biochemical Recurrence of Prostate Cancer After ProstatectomyBum-Sup Jang, Seok-Joo Chun, Jin Ho Kim
The Prostate|May 3, 2026
Insights and Limitations in Evaluating Testosterone Recovery With LHRH Antagonists and AgonistsSatı Coşkun Yazgan, Emre Yekedüz, Yüksel Ürün
The Prostate|April 29, 2026
A Gene Expression Tumor Signature Optimizing Partial Area-Under-the-Curve (pAUC) to Improve Specificity for Indolent Prostate CancerTravis A Gerke, Svitlana Tyekucheva, Konrad H Stopsack, et al.
The Prostate|April 17, 2026
Protein Kinase D1 Translocates PARP1 to the Membrane and Is Associated With Increased Sensitivity to Cell Viability Inhibition by PARP1 Inhibitor OlaparibSanjeev Shukla, Joseph McGrath, Robert Willis, et al.
Pageof 592

Showing results (1411-1420 of 5,911) with videos related to

Sort By:
Pageof 592
The Prostate|March 30, 2026
Impact of Intraprostatic Simultaneous Integrated Boost on Long-Term Outcomes in Unfavorable Intermediate-Risk Prostate Cancer Treated With Dose-Escalated Radiotherapy and Short-Term Androgen Deprivation TherapyCem Onal, Aysenur Elmali, Birhan Demirhan, et al.
The Prostate|March 31, 2026
A Two-Factor Bedside Prognostic Score Integrating Eastern Cooperative Oncology Group (ECOG) Performance Status and Aggressive Metastatic Burden in Metastatic Hormone-Sensitive Prostate CancerKoichiro Kurokawa, Satoshi Yamamoto, Yasutaka Yamada, et al.
The Prostate|March 18, 2026
Exploring the Gut-Prostate Axis: Microbial Signatures Linked to Prostate Volume and Bladder FunctionJonathan Surber, Marie Lork, Yasser Morsy, et al.
The Prostate|March 30, 2026
Development of Machine Learning Models for Predicting Prostate Cancer in Biopsy Candidates Using Prostate-Specific Antigen, Magnetic Resonance Imaging, and Hematologic ParametersDeniz Noyan Özlü, Yusuf Arıkan, Büşra Emir, et al.
The Prostate|May 3, 2026
Non-Cancer Causes of Death in Patients With Metastatic Hormone-Sensitive Prostate Cancer: A Real-World AnalysisMarta Garcia de Herreros, Clara Rodrigo, Laura Ferrer-Mileo, et al.
The Prostate|May 3, 2026
Perioperative Safety and Early Oncologic Outcomes of Salvage Irreversible Electroporation for Radiorecurrent Prostate CancerJarrett Noakes, Katherine Wainwright, Elias Hyams
The Prostate|May 3, 2026
Temporal Patterns and Resolution of Toxicities Following Hypofractionated Salvage Radiotherapy for Biochemical Recurrence of Prostate Cancer After ProstatectomyBum-Sup Jang, Seok-Joo Chun, Jin Ho Kim
The Prostate|May 3, 2026
Insights and Limitations in Evaluating Testosterone Recovery With LHRH Antagonists and AgonistsSatı Coşkun Yazgan, Emre Yekedüz, Yüksel Ürün
The Prostate|April 29, 2026
A Gene Expression Tumor Signature Optimizing Partial Area-Under-the-Curve (pAUC) to Improve Specificity for Indolent Prostate CancerTravis A Gerke, Svitlana Tyekucheva, Konrad H Stopsack, et al.
The Prostate|April 17, 2026
Protein Kinase D1 Translocates PARP1 to the Membrane and Is Associated With Increased Sensitivity to Cell Viability Inhibition by PARP1 Inhibitor OlaparibSanjeev Shukla, Joseph McGrath, Robert Willis, et al.
Pageof 592